Breaking News on Global Pharmaceutical Technology & Manufacturing

Hot Topics > Lifecycle management

Elan mulls hiving-off drug delivery business again

20-Apr-2010 - Irish drugmaker Elan has once again raised the possibility of selling its delivery business, Elan Drug Technologies (EDT).

FDA: Apotex response to GMP warning “inadequate”

15-Apr-2010 - The US Food and Drug Administration (FDA) has issued Apotex with another warning letter about cGMP violations at two plants explaining the firm’s response to previous warnings “is inadequate and...

Has Hospira beaten Myriad in Javelin competition?

13-Apr-2010 - US drugmaker Javelin Pharmaceuticals says Hospira’s takeover bid is “superior” and terminates agreement with Myriad Pharmaceuticals (MPI).

Alvogen signs up for Penwest’s Timerx tech

12-Apr-2010 - US delivery specialist Penwest is to apply its Timerx tech to “complex” generic pharmaceuticals in a development and commercialisation pact with non-branded drugmaker Alvogen.

Sanofi rejigs French ops; teams with AgaMatrix on glucose monitors

01-Apr-2010 - Sanofi-Aventis says French manufacturing operations will focus on vaccine and biotech drugs, unveiling €150m ($202m) plan to shift emphasis away from synthetic chemistry-based production.

Thermo takes over trial supply production at Lilly Indy plant

29-Mar-2010 - Thermo Fisher Scientific will take charge of clinical trial material production at Eli Lilly’s research technology facility in Indianapolis as the pharmaceutical firm further reduces in-house capacity to cut costs....

Anticancer APIs drive ScinoPharm gains in 2009

25-Mar-2010 - Contract manufacturing organization (CMO) ScinoPharm says strong anticancer API sales and growing demand in Europe and Asia were key to record performance in 2009.

News in brief

EWP says manufacturing line at West African firm operational soon

23-Mar-2010 - A Ghanian drugmaker will soon start producing generic pharmaceuticals for the West African market, according to investment group Emerging World Pharma.

News in brief

US drug sector increased R&D spending 2% in 2009

18-Mar-2010 - US pharmaceutical and biotechnology firms spent a record $65bn (€48bn) on drug and vaccine R&D in 2009, says a new study by the Pharmaceutical Research and Manufacturers of America (PhRMA)...

Irish pharma sector must attract R&D to secure competitve edge, says PCI

18-Mar-2010 - Ireland must become an R&D hub as well as a drug manufacturing destination to prosper in the increasingly competitive global pharmaceutical market, says industry body PharmaChemical Ireland (PCI).

Prosonix launches UMAX particle tech for respiratory drugs

17-Mar-2010 - Prosonix’ new UMAX particle engineering technology is set to “revolutionise” the field of respiratory medicines, according to company CEO David Hipkiss.

FDA wants more data on Afrezza's "clinical utility"; MannKind's shares fall

16-Mar-2010 - US Food and Drug Administration (FDA) request for more Afrezza data is not safety related and will not require new clinical trials, says developer MannKind.

Sigma adds big name small molecules to portfolio in Pfizer deal

15-Mar-2010 - Drug researchers will have greater access to some top selling molecules, including currently patented compounds atorvastatin, sildenafil and celecoxib, thanks to Sigma Aldrich’s new bioactives deal with US drug major...

News in brief

AstraZeneca to sell branded generics in deal with Torrent

15-Mar-2010 - AstraZeneca targets global generics market in license and supply deal with Indian manufacturer Torrent Pharma.

FDA OK for Haupt Pharma’s Italian antibiotics plant

01-Mar-2010 - US FDA clearance for Italian antibiotics production facility is important for global growth says German contract development and manufacturing organisation (CDMO) Haupt Pharma.

Aptuit unveils new solid state chemistry screen

18-Feb-2010 - US group Aptuit has bolstered its chemistry offering with a new solid state chemistry screen that it says will enable better decisions during drug formulation development and process scale-up.

Merck & Co to reduce workforce 15%

17-Feb-2010 - Merck & Co says manufacturing and R&D jobs will go as part of the post acquisition workforce reduction programme it announced yesterday.

Sohm: deal is boost for capacity and profitability

11-Feb-2010 - Generics firm Sohm says deal with manufacturer in Himachal Pradesh doubles capacity, cuts costs 6 per cent and increases profitability.

Deals dominate developments in drug delivery space

02-Feb-2010 - In-PharmaTechnologist presents a round up of recent developments in the field of drug delivery, with new deals for Starpharma and Penwest, and a regulatory filing for Hovione.

Watson buys Eden Biodesign

01-Feb-2010 - US generics group Watson Pharmaceuticals has bought UK contract biomanufacturing specialist Eden Biodesign.

AZ plans 8,000 job cuts by 2014 and will outsource more R&D

29-Jan-2010 - AstraZeneca will cut 8,000 more jobs by 2014 with R&D and supply chain operations being the main focus of the cutbacks.

Crospon spins out transdermal patch

28-Jan-2010 - Crospon has spun out its transdermal controlled release patch into a distinct company, two years after it licensed the system from HP, using funding from a pharma firm to further...

LTS teams up with IntelGenx on VersaFilm

26-Jan-2010 - LTS Lohmann Therapie-Systeme (LTS) signs up as manufacturer of drugs that use IntelGenx’s VersaFilm delivery technology.

Lupin's Mandideep plant OKed by US FDA

21-Jan-2010 - Indian drugmaker Lupin can start seeking US approval for new drugs made at its API plant in Mandideep, Bhopal after resolving the cGMP deficiencies that earned the facility a US...

Access’ oral insulin shows preclinical promise

20-Jan-2010 - Access Pharmaceuticals’ insulin diabetes treatment has shown promise in preclinical trials, achieving over 80 per cent oral bioavailability, leading the company to target proof-of-concept studies in humans.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...